creation date: 2026-06-18 21:21
tags: Pathologies


Toxidromes

Background

Toxidromes are a group of signs and symptoms that occur together, indicating a specific class of substance poisoning. This allows for rapid assessment and initiation of treatment without identifying the exact responsible agent.

More information is available by calling poisoning control:

  • National: 1-844-POISON-X
  • Ontario: 1-844-764-7669
  • Have the following prior to calling: patient age, weight, medical history, substance involved, amount and time of exposure, current vitals and symptoms, and any interventions performed

Clinical Syndrome

Anticholinergic

Mechanism of Toxicity

Blocks muscarinic receptors, preventing acetylcholine binding, leading to parasympathetic nervous system inhibition.

These receptors are found in the CNS, heart, and peripheral postganglionic cholinergic nerves in smooth muscles (intestinal and bronchial), secretory glands (salivary and sweat), and ciliary body of the eye.

Note, anticholinergic agents do not antagonize nicotinic acetylcholine receptors, and thus is technically better described as “antimuscarinic toxicity”

Clinical Presentation

  • Hyperthermia (“hot as a hare”)
  • Mydriasis (“blind as a bad”)
  • Dry skin and mucous membranes (“dry as a bone”)
  • Flushed skin from vasodilation (“red as a beet”)
  • Agitation and hallucinations (“mad as a hatter”)

Note, dry and flushed skin is key to differentiating from sympathomimetic toxidrome.

Common Causes

  • Tricyclic antidepressants
  • Antihistamines
  • Atropine
  • Scopolamine

Sympathomimetic

Mechanism of Toxicity

Mimics the action of the sympathetic nervous system, triggering fight-or-flight response.

Clinical Presentation

  • Tachycardia
  • Hypertension
  • Hyperthermia
  • Diaphoresis
  • Mydriasis
  • Agitation, paranoia, delusions

Note, sweaty and pale skin is key to differentiating from anticholinergic toxidrome.

Common Causes

  • Stimulants
    • Cocaine
    • Amphetamine
    • Methamphetamine
  • Pseudoephedrine, methylphenidate
  • MDMA
  • Synthetic cathinones
  • High doses of caffeine

Sedative-Hypnotic

Mechanism of Toxicity

Enhances GABA neurotransmitter effects resulting in CNS depression.

Clinical Presentation

  • Decreased level of consciousness (ranging from confusion to coma)
    • Slurred speech
    • Ataxia
  • Respiratory depression
  • Hypotension
  • Hypothermia
  • Normal or slightly constricted pupils and nystagmus

Common Causes

  • Benzodiazepines
  • Barbituates
  • Sleep medications (eg. zolpidem, zopiclone)
  • Alcohol
  • Gamma-hydroxybutyrate

Opioid

Mechanism of Toxicity

Activation of opioid receptors results in sedative effect and significant respiratory depression.

Clinical Presentation

  • Decreased level of consciousness (ranging from confusion to coma)
    • Slurred speech
    • Ataxia
  • Respiratory depression with significant bradypnea
  • Hypotension
  • Hypothermia
  • Pinpoint pupils

Note, pinpoint pupils and bradypnea is key to differentiating from sedative-hypnotic toxidrome. Additionally, a trial of naloxone can confirm.

Common Causes

  • Opioids (prescriptions or illicit)

Cholinergic

Mechanism of Toxicity

Excess acetylcholine activates muscarinic and nicotinic receptors, stimulating the parasympathetic nervous system.

Clinical Presentation

Fluids and secretions from everywhere:

  • Diaphoresis
  • Bronchorrhea
  • Lacrimation
  • Salivation
  • Urination
  • Diarrhea
  • Emesis
  • Bradycardia
  • Miosis
  • Bronchospasm
  • Seizures
  • Excitation of skeletal muscles

Common Causes

  • Organophosphate pesticides
  • Carbamate insecticides
  • Nerve agents
  • Certain mushrooms
  • Physostigmine, pyridostigmine

Cardiovascular Drug

Mechanism of Toxicity

Direct effect on cardiac conduction, myocardial contractility, and vascular tone. Has downstream effect on heart rhythm and blood pressure regulation.

Clinical Presentation

Common findings:

  • Refractory bradycardia
  • Hypotension
  • AV blocks
  • QRS prolongation
  • Changes in mental status due to impaired cerebral perfusion

Drug-specific findings:

  • Beta blockers: hypoglycemia, bronchospasm, seizures
  • Calcium channel blockers: hyperglycemia, bowel ischemia
  • Digoxin: visual disturbances, nausea, vomiting, hyperkalemia

Common Causes

  • Beta-blockers
  • Calcium channel blockers
  • Cardiac glycosides (digoxin)
  • Antiarrhythmics

Investigations

History & Physical

Critical components of a toxic exposure history includes:

  • Substance identification
    • Exact name and formulation
    • Concentration of toxin
  • Time of exposure
    • Acute vs. chronic ingestion
  • Quantity and formulation
    • Number of pills, volume, or estimated amount
    • Immediate vs. extended release
  • Intent and co-ingestants
    • Accidental vs. intentional ingestion
    • Identify any co-ingestants (eg. alcohol)

Physical exam should note vitals:

  • Temperature
  • Heart rate
  • Blood pressure
  • Respiratory rate

Laboratory Studies

Every patient with toxicity should have the following investigations:

  • Electrolytes and blood gases
  • Osmolar gap components
  • ECG
  • Co-ingestants (acetaminophen and salicylate concentration)

Additionally, a number of routine studies are done, although not strictly necessary:

  • CBC
  • Extended electrolytes
  • Creatinine

Management

Stabilization

Ensure ABCs

  • Evaluate airway patency and consider early intubation as needed
  • Supplemental oxygen as needed, monitor O2 sat
  • Establish IV access

Trauma and temperature
Conduct a thorough examination of neurological status and exposure. Monitor temperature and cool if hyperthermic.

Decontamination

Activated Charcoal

Mechanism of action

  • Absorbs toxins in the gastrointestinal tract

Indications

  • Toxic ingestions within 1-2 hours that can be absorbed by AC
  • Patient must have intact airway protection to prevent aspiration

Administration

  • Adults: 50-100g as slurry
  • Children 1-2g/kg
  • Can be multiple doses or single dose

Contraindications

  • Unprotected airway
  • Altered mental status
  • Caustic ingestions
  • Bowel obstruction
  • Ingestion of non-absorbable toxins (eg. alcohol, metals, lithium)

Gastric Lavage

Mechanism of action

  • Directly removes toxins from stomach through orogastric tube via flush and suction

Indications

  • Life-threatening ingestions within 1 hour
  • No safer alternative

Administration

  1. Secure airway typically via intubation
  2. Large bore (36-40 Fr in adults) orogastric tube
  3. Flush with 50-100 mL tepid water or saline until clear return

Contraindications

  • Caustic or hydrocarbon ingestion
  • Unprotected airway
  • Esophageal disease or varices
  • Ingestion occurred >1 hour ago (relative CI)

Whole Bowel Irrigation

Mechanism of action

  • Large volumes of PEG solution used to mechanically flush the GI tract

Indications

  • Sustained-release medications
  • Drug packets from body packers/stuffers
  • Drugs not absorbed by charcoal
  • Heavy metals like lead/metal fragments

Administration

  • PEG solution given orally or via NG tube, given until rectal effluent is clear
  • Adults: 1-2 L/hr
  • Children: 25 mL/kg/hr

Contraindications

  • Bowel obstruction, perforation, or ileus
  • Hemodynamic instability
  • Unprotected airway
  • Significant GI bleeding

Antidotes

Antidotes may be available depending on the toxin. These pharmacologically reverse/neutralize the effects.

Common pairs:

  • Opioids: naloxone
  • Acetaminophen: N-acetylcysteine
  • Toxic alcohols: fomepizole/ethanol
  • Benzodiazepine: flumazenil
  • Anticholinergics: physostigmine

Very few drugs have antidotes and in such case, poison control will advise on their use.

Enhanced Elimination (Dialysis)

Dialysis can remove toxins directly from the bloodstream. This is indicated for:

  • Severe toxicity unresponsive to supportive care
  • End-organ damage (eg. renal or liver failure)
  • Live-threatening lab abnormalities

Specific toxins that calls for immediate dialysis are:

  • Methanol
  • Ethylene glycol
  • Lithium
  • Salicylates

Disposition

Patients can be discharged if:

  • Asymptomatic after observation
  • No risk of delayed toxicity
  • Predictable toxicokinetics
  • Psychiatric clearance if intentional ingestion

Admission is indicated for:

  • Persistent symptoms needing treatment
  • Anticipated delayed toxicity
  • Need for antidotes/dialysis
  • Psychiatric evaluation

ICU care is indicated for:

  • Hemodynamic instability
  • Respiratory insufficiency
  • Severe altered mental status
  • Antidote complications
  • Severe acid-base/electrolyte imbalances

References

Tools / Guidelines

Additional Reading

Goldfrank’s Toxicologic Emergencies, 11e